AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Merck has followed its $620 M takeover of Rosetta Inpharmics with a $91 bn (EUR 102.8 bn) bid for its rival Schering-Plough.
The figures give details of Merck and Schering-Plough turnover and net profit for 1999 and 2000.
Merck turnover increased from $32.7 bn in 1999 to $40.4 bn in 2000 with net profit increasing from …